s6y
Company name or ticker
Search
ARS Pharmaceuticals, Inc.
3
Smith Margaret Ekins: Initial statement of beneficial ownership of securities
Filed
Monday, August 17, 2026
Period
Aug 17, 2026
Accession number
0002149973-26-000002
Documents
form3-08172026_080834.xml
3
ex24-08172026_080837.htm
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header